improvement

Phemex Upgrades RPI Ecosystem, Setting New Liquidity Benchmarks Across 210+ Pairs

APIA, Samoa, Dec. 26, 2025 /PRNewswire/ -- Phemex, a user-first crypto exchange, has announced a major upgrade to its Retail Price…

2 weeks ago

Conversational English Improvement Startup EnglishYaari Secures 1 Crore Funding at 10 Crore Valuation, Bihar Startup Founders Plan Scaling to 50 cr ARR by 2027

LAKHISARAI, India, Dec. 23, 2025 /PRNewswire/ -- EnglishYaari, a platform to help professionals improve their English communication, has raised ₹1…

2 weeks ago

Corti Unlocks “Surgical” AI Improvement, Outperforming Big Tech in Interpretability Benchmark

New "GIM" method tops MIB global leaderboard, offering the industry a scalable way to inspect and improve billion-parameter models.COPENHAGEN, Denmark…

3 weeks ago

Dyne Therapeutics Announces Pricing of Upsized $350.0 Million Public Offering of Common Stock

December 09, 2025 21:42 ET  | Source: Dyne Therapeutics, Inc. WALTHAM, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc.…

4 weeks ago

Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025

– New findings demonstrate a 72% HI-E response rate at Week 16 with meaningful hemoglobin improvement –– Strong activity observed…

1 month ago

Built for Better: Srixons New ZXiR Irons Redefine Game Improvement

HUNTINGTON BEACH, Calif., Dec. 4, 2025 – Expanding its acclaimed ZXi Iron family into the game improvement category like never…

1 month ago

Hydreight Reports 132% YoY Revenue Increase in Q3 2025 and Fourth Consecutive Quarter of Profitability, Highlighting Strong Multi-Vertical Performance

“The quarter reflects broad growth across all verticals, expanding VSDHOne adoption, and strategic investments aimed at supporting margin improvement and…

1 month ago

Varvee Global Limited (VGL) Posts Strong Operational Profit & EBDITA for Q2FY26: +80% Revenue Growth, 49.8% EBITDA Margin; PAT +23.5% YoY; H1 PAT +15.7% and Attaining Near-Zero Debt

AHMEDABAD, India, Nov. 13, 2025 /PRNewswire/ -- VGL Limited ("VGL" or the "Company") today reported results for the quarter (Q2…

2 months ago

LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE

Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase 2b study met primary endpoint. No symptomatic intracranial…

2 months ago

Innoviti Posts 35% Revenue Growth in FY25

Strong execution across all product lines led to gross margin improvement by 44% BANGALORE, India, Oct. 23, 2025 /PRNewswire/ --…

2 months ago